Yavne, Israel

Erez Bar-Haim


Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Yavne, IL (2006 - 2010)
  • Rehovot, IL (2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Erez Bar-Haim: Innovator in Anti-Tumor Vaccines

Introduction

Erez Bar-Haim is a notable inventor based in Yavne, Israel. He has made significant contributions to the field of immunology, particularly in the development of anti-tumor vaccines. With a total of 3 patents to his name, Bar-Haim's work focuses on tumor-associated antigen peptides.

Latest Patents

Bar-Haim's latest patents include innovative approaches to tumor-associated antigen (TAA) peptides. These patents detail the use of TAA peptides derived from various sources, including Uroplakin Ia, Ib, II, and III, Prostate Specific Antigen (PSA), Prostate Acid Phosphatase (PAP), and Prostate Specific Membrane Antigen (PSMA). The inventions aim to utilize these peptides as anti-tumor vaccines to prevent or cure cancers such as bladder, prostate, and breast cancer. Most notably, the patents emphasize the presentation of these peptides to the immune system by HLA-A2 molecules, enhancing their effectiveness in cancer treatment.

Career Highlights

Erez Bar-Haim is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research in cancer immunotherapy. His work has garnered attention for its potential to revolutionize cancer treatment through innovative vaccine strategies.

Collaborations

Bar-Haim collaborates with esteemed colleagues, including Lea Eisenbach and Adrian Paz, who contribute to his research endeavors. Their combined expertise enhances the development of effective anti-tumor vaccines.

Conclusion

Erez Bar-Haim stands out as a pioneering inventor in the field of anti-tumor vaccines, with a focus on tumor-associated antigen peptides. His contributions have the potential to significantly impact cancer treatment and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…